Topics

Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones

06:19 EDT 15 Aug 2019 | Synbiobeta

Customers Choose from a Wider Spectrum of Flavor Profiles  BOSTON, Aug. 12, 2019 /PRNewswire/ — Conagen, a Boston-based biotechnology company focusing on research and development, announced today its breakthrough development in the commercial production of natural aromatic compound, γ-Decalactone from natural substrates using its proprietary technology. Found in many ripe fruits and particularly peaches, γ-Decalactone […]

The post Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones appeared first on SynBioBeta.

Original Article: Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones

NEXT ARTICLE

More From BioPortfolio on "Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...